Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neoplasma (Bratislava)

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.4149/NEO_2009_03_208PMID 19309223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms.

  2008cited by this paper
• Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance.

  2007cited by this paper
• Methyl-β-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil : Involvement of akt, NF-κB and bcl- 2

  2006cited by this paper
• The development of platinum compounds and their possible combination.

  2006cited by this paper
• Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations

  2006cited by this paper
• NF‐κB activation is required for cisplatin‐induced apoptosis in head and neck squamous carcinoma cells

  2006cited by this paper
• Differential effects of NF-κB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome

  2006cited by this paper
• NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells.

  2006cited by this paper
• Methyl-beta-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: involvement of Akt, NF-kappaB and Bcl-2.

  2006cited by this paper
• Recent advances in management of patients with platinum‐refractory testicular germ cell tumors

  2006cited by this paper
• Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.

  2006cited by this paper
• Platinum transporters and drug resistance

  2006cited by this paper
• Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.

  2006cited by this paper
• Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.

  2005cited by this paper
• Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells

  2005influential reference
• Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate.

  2005cited by this paper
• Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells.

  2005cited by this paper
• Biological and chemical inhibitors of NF‐κB sensitize SiHa cells to cisplatin‐induced apoptosis

  2005cited by this paper
• Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells

  2005cited by this paper
• Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.

  2005cited by this paper
• Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: a role of c-Jun NH2-terminal kinase 1.

  2005cited by this paper
• Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.

  2005cited by this paper
• Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease.

  2005influential reference
• Confocal Microscopic Analysis of the Interaction between Cisplatin and the Copper Transporter ATP7B in Human Ovarian Carcinoma Cells

  2004cited by this paper
• Mitogen-activated protein kinases in apoptosis regulation

  2004cited by this paper
• Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells

  2004cited by this paper
• Hypoxia Selection of Death-resistant Cells

  2004cited by this paper
• Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line.

  2004cited by this paper
• Expression of the IAPs in multidrug resistant tumor cells.

  2004cited by this paper
• AKT involvement in cisplatin chemoresistance of human uterine cancer cells.

  2004cited by this paper
• Difference in Expression of Bcl-2 and Bcl-xl Genes in Cisplatin- sensitive and Cisplatin-resistant Human in Ovarian Cancer Cell Lines

  2004influential reference
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated apoptosis.

  2003cited by this paper
• Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells*

  2003influential reference
• Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: implication for prevention against inflammation-related carcinogenesis.

  2003cited by this paper
• At the acidic edge: emerging functions for lysosomal membrane proteins.

  2003influential reference
• Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines

  2003cited by this paper
• Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases.

  2002cited by this paper
• Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells.

  2001cited by this paper
• Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments.

  2000cited by this paper
• Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells.

  2000cited by this paper
• Exosome: from internal vesicle of the multivesicular body to intercellular signaling device.

  2000cited by this paper
• BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma

  2000influential reference
• Synthesis of Ethyl 4-Isothiocyanatobutanoate Derivatives.

  1998cited by this paper
• Molecular Mechanisms of c-Jun N-terminal Kinase-mediated Apoptosis Induced by Anticarcinogenic Isothiocyanates*

  1998cited by this paper
• The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.

  1998cited by this paper
• Cellular accumulation of the anticancer agent cisplatin: a review.

  1993cited by this paper

• Salidroside, a Chemopreventive Glycoside, Diminishes Cytotoxic Effect of Cisplatin in Vitro

  2018cites this paper
• Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo.

  2015influential citation
• Original Article Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo

  2015cites this paper
• Proteasome inhibition leads to altered signaling in the proteome of cisplatin-resistant human ovarian carcinoma cell line.

  2013cites this paper
• Kinase regulation by sulfur and selenium containing compounds.

  2011cites this paper
• Sensitization of non-small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates.

  2010cites this paper
• Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin.

  2010cites this paper
• Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells

  2010influential citation